Christina A. Le
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christina A. Le has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Cole L. Martin
Graduate Biomedical Sciences Pathobiology, Physiology and Pharmacology Theme, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publication - Krystal L. Rivera‐Figueroa
Department of Biochemistry & Molecular Genetics University of Alabama at Birmingham Birmingham Alabama USA
1 shared publication - Leandra Cordero Oñate
CF Clinic, Department of Pediatrics Pulmonology Hospital Infantil Robert Reid Cabral Santo Domingo Dominican Republic
1 shared publication - Stephen G. Aller
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA
1 shared publication - Wilfredo De Jesús-Rojas
Department of Pediatrics and Basic Science, Ponce Health Sciences University, Ponce, PR 00716, USA, Puerto Rico
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (5) , e71648
Challenges to Assessing the Prevalence of Cystic Fibrosis in the Caribbean
: Cystic fibrosis (CF) is likely underdiagnosed in Caribbean populations due to non‐representative cystic fibrosis transmembrane conductance regulator (CFTR) variant screening panels, limited newborn screening programs, and structural healthcare barriers. Data from 2022 indicate substantial populations with European ancestry in Puerto Rico (1.4 M, 42.7%) and the Dominican Republic (1.4 M, 57.9%), yet the true burden of CF in the broader Caribbean remains largely undocumented. Working Hypothesis: Current diagnostic frameworks, largely based on European‐derived CFTR variant distributions, fail to capture the true burden of CF in Caribbean populations, leading to underestimated prevalence and delayed or missed diagnoses. Objectives: To synthesize registry, clinical, and published data to identify barriers to accurately assessing CF prevalence in Caribbean populations. Study Design and Methods: This narrative literature review integrates CF registries, published data on CFTR variant distribution, population ancestry data, and clinical observations from CF centers in Puerto Rico and the Dominican Republic. Clinical insights were derived from pediatric patients evaluated at the Pediatric Rare Lung and Asthma Institute in Puerto Rico and the CF Clinic at Robert Reid Cabral Children's Hospital in the Dominican Republic. Results: CFTR variant patterns differ from those in the United States, with higher frequencies of rare variants such as p.Ala559Thr. Standard screening panels may miss these variants, contributing to underdiagnosis. Limited newborn screening, misdiagnosis, and restricted access to CFTR modulator therapies further exacerbate disparities. Conclusions: Structural, diagnostic, and genetic factors hinder accurate CF prevalence estimates in the Caribbean, highlighting the need for region‐specific research, improved screening, and expanded access to therapies.
- 5 May 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (5) , e71648
Open AccessChallenges to Assessing the Prevalence of Cystic Fibrosis in the Caribbean
: Cystic fibrosis (CF) is likely underdiagnosed in Caribbean populations due to non‐representative cystic fibrosis transmembrane conductance regulator (CFTR) variant screening panels, limited newborn screening programs, and structural healthcare barriers. Data from 2022 indicate substantial populations with European ancestry in Puerto Rico (1.4 M, 42.7%) and the Dominican Republic (1.4 M, 57.9%), yet the true burden of CF in the broader Caribbean remains largely undocumented. Working Hypothesis: Current diagnostic frameworks, largely based on European‐derived CFTR variant distributions, fail to capture the true burden of CF in Caribbean populations, leading to underestimated prevalence and delayed or missed diagnoses. Objectives: To synthesize registry, clinical, and published data to identify barriers to accurately assessing CF prevalence in Caribbean populations. Study Design and Methods: This narrative literature review integrates CF registries, published data on CFTR variant distribution, population ancestry data, and clinical observations from CF centers in Puerto Rico and the Dominican Republic. Clinical insights were derived from pediatric patients evaluated at the Pediatric Rare Lung and Asthma Institute in Puerto Rico and the CF Clinic at Robert Reid Cabral Children's Hospital in the Dominican Republic. Results: CFTR variant patterns differ from those in the United States, with higher frequencies of rare variants such as p.Ala559Thr. Standard screening panels may miss these variants, contributing to underdiagnosis. Limited newborn screening, misdiagnosis, and restricted access to CFTR modulator therapies further exacerbate disparities. Conclusions: Structural, diagnostic, and genetic factors hinder accurate CF prevalence estimates in the Caribbean, highlighting the need for region‐specific research, improved screening, and expanded access to therapies.